FBIOP
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred StockstockNASDAQPreferred Stock
At CloseNov 18, 2026
13.95USD+1.639%(+0.23)10,883
FBIOP Financials
In Q3 FY 2026 (ended ), Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) reported revenue of $19.16M, net income of −$5.85M, operating cash flow of −$6.2M, and assets of $280.22M (filed ).
Loading financial statements…
